Featured essay
CRO Consolidation Drives Clinical Services M&A: Buyer ImplicationsModern Catalyst The CRO landscape is undergoing a structural realignment driven by pharma sponsors' demand for integrated, end-to-end clinical services and the strategic imperative for CROs to consolidate therapeutic expertise. CRO consolidation in clinical trials has…
Read full essay